The Antifibrotic Effect of A<sub>2B</sub> Adenosine Receptor Antagonism in a Mouse Model of Dermal Fibrosis

Harry Karmouty‐Quintana(The University of Texas Health Science Center), Tingting Weng(The University of Texas Health Science Center at Houston), Jose G. Molina(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Brent Gudenkauf(Houston Methodist), Shervin Assassi(The University of Texas Health Science Center at Houston), Junsuk Ko(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Chiara Bellocchi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sandeep K. Agarwal(Baylor College of Medicine), Kemly Philip(The University of Texas Health Science Center), Michael R. Blackburn(The University of Texas Health Science Center at Houston), Ning‐Yuan Chen(Yale University), Hongyan Zhong(Gilead Sciences (United States)), Minghua Wu(Northwestern University), Scott D. Collum(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Arthritis & Rheumatology
May 17, 2018
10.1002/art.40554
Cited by 21

Related Papers

Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis
|Science|2007|412
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
|American Journal of Respiratory and Critical Care Medicine|2013|247
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
|American Journal Of Pathology|2009|227
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
|Arthritis & Rheumatology|2024|162
Beneficial Role of Erythrocyte Adenosine A2B Receptor–Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia
|Circulation|2016|144